{"id":68010,"date":"2026-10-31T14:36:45","date_gmt":"2026-10-31T09:06:45","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=68010"},"modified":"2026-10-31T15:12:09","modified_gmt":"2026-10-31T09:42:09","slug":"new-series-of-interactive-cardiology-mcqs-19","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/","title":{"rendered":"New Series of Interactive Cardiology MCQs 19"},"content":{"rendered":"\n<!-- Cardiology MCQs Part 19 (Full 25 Questions) - WordPress Safe Custom HTML Block -->\n<script src=\"https:\/\/cdn.tailwindcss.com?plugins=forms,typography,aspect-ratio\"><\/script>\n<script>\n  tailwind.config = {\n    corePlugins: { preflight: false }\n  }\n<\/script>\n\n<div id=\"mcq19-quiz-wrapper\" class=\"font-sans bg-slate-950 text-slate-100 p-4 md:p-8 rounded-3xl max-w-4xl mx-auto shadow-2xl relative overflow-hidden my-8 border border-solid border-emerald-500\/20\" style=\"box-sizing: border-box;\">\n  \n  <!-- Background Accents -->\n  <div class=\"absolute top-0 left-0 w-full h-full pointer-events-none opacity-10 bg-[radial-gradient(ellipse_at_center,_var(--tw-gradient-stops))] from-emerald-500 via-teal-900 to-slate-950\"><\/div>\n  \n  <!-- Header Banner -->\n  <div class=\"relative text-center pb-6 border-b border-solid border-emerald-500\/25 mb-8\">\n    <div class=\"inline-block bg-gradient-to-r from-emerald-500 via-teal-600 to-cyan-600 text-white font-black text-xs md:text-sm px-4 py-1.5 rounded-full uppercase tracking-wider shadow-lg mb-3 animate-pulse\">\n      \ud83e\uddec Advanced Cardiology Series &#8211; Part 19\n    <\/div>\n    <h1 class=\"text-3xl md:text-5xl font-extrabold tracking-tight text-transparent bg-clip-text bg-gradient-to-r from-emerald-300 via-teal-400 to-cyan-400 m-0\">\n      Interactive Cardiology MCQs #19\n    <\/h1>\n    <p class=\"text-sm md:text-lg text-slate-300 mt-2 max-w-2xl mx-auto font-medium\">\n      Post-Graduate Level Clinical, Imaging, EP &amp; Structural Masterclass\n    <\/p>\n  <\/div>\n\n  <!-- Real-Time Floating Scoreboard -->\n  <div class=\"sticky top-4 z-40 bg-slate-900\/90 backdrop-blur-md border-2 border-solid border-emerald-500\/40 rounded-2xl p-4 mb-8 shadow-xl flex flex-wrap items-center justify-between gap-4\">\n    <div class=\"flex items-center gap-3\">\n      <div class=\"text-3xl\">\ud83c\udfc6<\/div>\n      <div>\n        <div class=\"text-[10px] uppercase font-extrabold tracking-widest text-emerald-300\">Live Scoreboard<\/div>\n        <div class=\"text-lg md:text-2xl font-black text-teal-300 flex items-center gap-1\">\n          <span id=\"mcq19-correct-count\">0<\/span><span class=\"text-slate-500 text-sm md:text-lg\">\/ 25 Correct<\/span>\n        <\/div>\n      <\/div>\n    <\/div>\n    <div class=\"flex items-center gap-2 bg-slate-950\/80 px-4 py-2 rounded-xl border border-solid border-slate-800\">\n      <span class=\"text-xs font-bold text-slate-400 uppercase tracking-wider\">Progress:<\/span>\n      <div class=\"w-24 md:w-36 bg-slate-800 h-3 rounded-full overflow-hidden\">\n        <div id=\"mcq19-progress-bar\" class=\"bg-gradient-to-r from-emerald-500 to-teal-500 h-full w-0 transition-all duration-300 rounded-full\"><\/div>\n      <\/div>\n      <span class=\"text-xs font-bold text-teal-300\"><span id=\"mcq19-answered-count\">0<\/span>\/25<\/span>\n    <\/div>\n  <\/div>\n\n  <!-- Quiz Questions Container -->\n  <div class=\"space-y-8 relative\">\n\n    <!-- Q1 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q1<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention (PCI) for an Acute Coronary Syndrome (ACS), the AUGUSTUS trial provided critical guidance on antithrombotic regimens. What was its primary finding regarding the safety of omitting aspirin?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Omitting aspirin actually reduced major bleeding without significantly increasing stent thrombosis. Reference: 2023 ESC Guidelines for the management of ACS.\">A) Omitting aspirin led to unacceptably high rates of acute stent thrombosis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The AUGUSTUS trial demonstrated that a dual antithrombotic regimen (a DOAC like apixaban + a P2Y12 inhibitor like clopidogrel) without aspirin resulted in significantly less bleeding and fewer hospitalizations compared to regimens that included aspirin (triple therapy), without an excess of ischemic events. Reference: 2023 ESC Guidelines for the management of ACS.\">B) A dual regimen (DOAC + P2Y12 inhibitor) without aspirin significantly reduced bleeding compared to triple therapy without increasing ischemic events.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Triple therapy was associated with higher bleeding, not lower mortality. Reference: 2023 ESC Guidelines for the management of ACS.\">C) Triple therapy (DOAC + Aspirin + P2Y12 inhibitor) remains mandatory for 12 months for mortality reduction.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aspirin monotherapy is never appropriate for preventing stent thrombosis post-PCI in AFib patients. Reference: 2023 ESC Guidelines for the management of ACS.\">D) Aspirin monotherapy is superior to DOAC therapy for both bleeding and ischemic outcomes.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q2 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q2<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Patients supported with continuous-flow Left Ventricular Assist Devices (cf-LVADs) frequently develop severe gastrointestinal bleeding. What unique acquired hematological disorder is the primary driver of this complication?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While patients are on Warfarin, the primary unique driver of GI bleeding in cf-LVAD patients is an acquired protein defect. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">A) Supratherapeutic Warfarin toxicity due to hepatic congestion.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"High shear stress from the continuous-flow rotor mechanically unfolds and destroys high-molecular-weight von Willebrand factor (vWF) multimers. This leads to acquired von Willebrand syndrome, profoundly increasing the risk of bleeding from GI angiodysplasias. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">B) Acquired von Willebrand syndrome due to mechanical destruction of high-molecular-weight multimers.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"HIT occurs but is not the universal primary cause of chronic GI bleeding in LVAD patients. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">C) Heparin-Induced Thrombocytopenia (HIT) Type II.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Factor V Leiden causes hypercoagulability (thrombosis), not bleeding. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">D) Acquired Factor V Leiden mutation.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q3 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q3<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During Tissue Doppler Imaging (TDI) of the mitral annulus to evaluate a patient for Constrictive Pericarditis versus Restrictive Cardiomyopathy, the sonographer notes &#8220;Annulus Reversus.&#8221; What exactly does this sign describe?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In normal patients, the lateral mitral annulus moves faster (higher e' velocity) than the medial annulus. In Constrictive Pericarditis, the lateral annulus is tethered and restricted by the fibrotic pericardium, causing its velocity to drop below the medial annulus velocity. This paradoxical reversal (medial e' &gt; lateral e') is called Annulus Reversus and is highly specific for constriction. Reference: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.\">A) The medial e&#8217; velocity is paradoxically greater than the lateral e&#8217; velocity.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes a restrictive pattern (very stiff LV), not annulus reversus. Reference: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.\">B) Both the medial and lateral e&#8217; velocities are profoundly depressed (&lt; 5 cm\/s).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The E\/A ratio reversing to &lt; 0.8 is impaired relaxation (Grade 1 diastolic dysfunction). Reference: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.\">C) The mitral inflow E\/A ratio reverses from &gt; 2.0 to &lt; 0.8 with inspiration.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This is the normal physiologic pattern. Reference: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.\">D) The lateral e&#8217; velocity is significantly greater than the medial e&#8217; velocity.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q4 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q4<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with known Congenitally Corrected Transposition of the Great Arteries (L-TGA) presents with progressive heart failure symptoms at age 40. Without any other structural interventions, what is the natural history and primary mechanism of heart failure in this condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The LV is pumping to the pulmonary circuit (low pressure); it does not usually fail from pressure overload. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">A) Failure of the systemic Left Ventricle due to severe pulmonary hypertension.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In L-TGA, there is atrioventricular and ventriculoarterial discordance. This means the morphologic Right Ventricle (RV) is in the systemic position, pumping to the aorta. The natural history is progressive failure of this systemic RV because its geometry and tricuspid valve are not designed to withstand lifelong systemic arterial pressures, often accompanied by severe tricuspid regurgitation. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">B) Failure of the systemic morphologic Right Ventricle, often complicated by severe tricuspid regurgitation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Severe dynamic LVOT obstruction is a feature of HOCM, not the primary failure mode of L-TGA. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">C) Severe dynamic Left Ventricular Outflow Tract (LVOT) obstruction.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While Eisenmenger syndrome can occur if there is a large VSD, L-TGA without associated defects primarily causes systemic RV failure. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">D) Rapid progression to Eisenmenger syndrome due to an obligate ASD.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q5 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q5<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Ivabradine is used to reduce heart rate and improve outcomes in patients with HFrEF (LVEF &lt;= 35%) who remain symptomatic despite maximally tolerated beta-blockers. In which of the following baseline rhythms is Ivabradine strictly CONTRAINDICATED because it will have zero efficacy?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Normal sinus rhythm with a resting HR &gt; 70 bpm is the precise, FDA-approved indication for Ivabradine. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">A) Normal Sinus Rhythm with a resting HR &gt; 70 bpm.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Sinus tachycardia is effectively treated by Ivabradine. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">B) Inappropriate Sinus Tachycardia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Ivabradine selectively inhibits the If ('funny') current in the Sinoatrial (SA) node. It has no effect on AV nodal conduction or ventricular tissue. Therefore, in Atrial Fibrillation (where the SA node is not driving the ventricular rate), Ivabradine is completely ineffective and contraindicated. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">C) Atrial Fibrillation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A patient with a first-degree AV block can safely take Ivabradine, as it does not affect AV node conduction. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">D) Normal Sinus Rhythm with a first-degree AV block.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q6 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q6<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During a right and left heart catheterization to investigate severe dyspnea, the operator notes complete equalization of diastolic pressures in the Right Atrium, Right Ventricle, Left Atrium (PCWP), and Left Ventricle. What does this hemodynamic finding strongly indicate?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"HOCM exhibits high LV diastolic pressures and gradients, but not pan-chamber equalization. Reference: Grossman &amp; Baim's Cardiac Catheterization, Angiography, and Intervention.\">A) Hypertrophic Obstructive Cardiomyopathy (HOCM).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Equalization of end-diastolic pressures across all four cardiac chambers (typically within 5 mmHg of each other) is the hemodynamic hallmark of Cardiac Tamponade (and to a lesser extent, Constrictive Pericarditis). The fluid-filled pericardial sac exerts a uniform external pressure that dictates the filling pressures of the entire heart. Reference: Grossman &amp; Baim's Cardiac Catheterization, Angiography, and Intervention.\">B) Cardiac Tamponade or Constrictive Pericarditis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Severe mitral stenosis causes a large gradient between the LA (PCWP) and LV diastolic pressure, preventing equalization. Reference: Grossman &amp; Baim's Cardiac Catheterization, Angiography, and Intervention.\">C) Severe Mitral Stenosis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Isolated RV infarction elevates RA and RV diastolic pressures, but LV and LA pressures often remain normal or low due to poor forward flow. Reference: Grossman &amp; Baim's Cardiac Catheterization, Angiography, and Intervention.\">D) Acute Right Ventricular Infarction.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q7 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q7<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with stable angina undergoes coronary angiography and physiological testing of an intermediate LAD lesion. The Instantaneous Wave-free Ratio (iFR) is measured. What is the validated cut-off value below which the lesion is considered hemodynamically significant?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This is the cutoff for Fractional Flow Reserve (FFR), which requires adenosine hyperemia. Reference: 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization.\">A) &lt;= 0.80<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This value is too low. Reference: 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization.\">B) &lt;= 0.75<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Unlike FFR, iFR is measured at rest during the wave-free period of diastole and does not require adenosine. Based on the DEFINE-FLAIR and iFR-SWEDEHEART trials, an iFR cut-off of &lt;= 0.89 indicates a hemodynamically significant stenosis warranting revascularization. Reference: 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization.\">C) &lt;= 0.89<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This represents near-normal flow. Reference: 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization.\">D) &lt;= 0.95<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q8 -->\n    <!-- Q8 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q8<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In patients with multi-vessel coronary artery disease presenting with a STEMI, the COMPLETE trial addressed the strategy of revascularizing non-culprit lesions. What did the trial demonstrate regarding complete revascularization versus culprit-lesion-only PCI?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Complete revascularization was actually superior to culprit-only PCI. Reference: 2023 ESC Guidelines for the management of ACS.\">A) Culprit-lesion-only PCI resulted in lower mortality compared to complete revascularization.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The COMPLETE trial definitively showed that in STEMI patients with multi-vessel disease, routine complete revascularization of angiographically significant non-culprit lesions significantly reduced the composite risk of cardiovascular death or myocardial infarction compared to a culprit-lesion-only strategy. Reference: 2023 ESC Guidelines for the management of ACS.\">B) Complete revascularization of non-culprit lesions significantly reduced the composite of CV death or MI compared to culprit-only PCI.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Complete revascularization was beneficial, not harmful, and did not increase stent thrombosis rates. Reference: 2023 ESC Guidelines for the management of ACS.\">C) Complete revascularization increased the rate of acute stent thrombosis and is contraindicated.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The COMPLETE trial did not require FFR for non-culprit lesions; angiographic severity (&gt;= 70%) was sufficient to show benefit. Reference: 2023 ESC Guidelines for the management of ACS.\">D) Complete revascularization was only beneficial if guided exclusively by FFR, but not by angiography alone.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q9 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q9<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          The presence of prominent &#8220;U waves&#8221; on an electrocardiogram, particularly in the mid-precordial leads (V2-V4), combined with ST-segment depression and flattened T waves, is the classic electrocardiographic hallmark of which electrolyte abnormality?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hyperkalemia causes tall, peaked T waves and widened QRS complexes, not prominent U waves. Reference: Chou's Electrocardiography in Clinical Practice.\">A) Severe Hyperkalemia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypercalcemia shortens the QT interval. Reference: Chou's Electrocardiography in Clinical Practice.\">B) Hypercalcemia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Hypokalemia alters ventricular repolarization. The classic ECG progression includes ST-segment depression, flattening or inversion of the T wave, and the emergence of prominent U waves (a positive deflection following the T wave), which can simulate a prolonged QT interval (actually a QU interval). Reference: Chou's Electrocardiography in Clinical Practice.\">C) Hypokalemia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypocalcemia prolongs the ST segment and QT interval, but does not classically produce prominent U waves. Reference: Chou's Electrocardiography in Clinical Practice.\">D) Hypocalcemia.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q10 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q10<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In suspected Cardiac Amyloidosis, a Technetium-99m Pyrophosphate (Tc-99m PYP) scan is performed. A Grade 3 uptake (radiotracer uptake in the myocardium greater than in the ribs) is highly sensitive and specific for which exact subtype of amyloidosis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"AL amyloidosis typically has Grade 0 or 1 uptake on a PYP scan. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">A) Light Chain (AL) Amyloidosis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A positive Tc-99m PYP scan (Grade 2 or 3 myocardial uptake) in the absence of a monoclonal protein in the blood\/urine is nearly 100% specific for Transthyretin (ATTR) Amyloid Cardiomyopathy. It non-invasively differentiates ATTR from AL amyloidosis, sparing the patient from an endomyocardial biopsy. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">B) Transthyretin (ATTR) Amyloidosis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Serum Amyloid A (AA) rarely involves the heart to a clinically significant degree and does not take up PYP tracer intensely. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">C) Serum Amyloid A (AA) Amyloidosis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Dialysis-related amyloidosis affects joints and bones, not primarily the myocardium. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">D) Dialysis-related (beta-2 microglobulin) Amyloidosis.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q11 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q11<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with a history of colon cancer presents with severe, rest chest pain immediately following their chemotherapy infusion. The ECG shows transient ST elevations that resolve with nitroglycerin. Which chemotherapeutic agent is notoriously responsible for profound coronary vasospasm?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Anthracyclines cause irreversible HFrEF, not acute vasospasm. Reference: 2022 ESC Guidelines on cardio-oncology.\">A) Doxorubicin (Anthracycline).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Fluoropyrimidines, specifically 5-Fluorouracil (5-FU) and its prodrug Capecitabine, are highly associated with severe, acute coronary vasospasm. This can present as angina, STEMI, or sudden cardiac death during or shortly after the infusion. Management includes stopping the drug and administering nitrates and calcium channel blockers. Reference: 2022 ESC Guidelines on cardio-oncology.\">B) 5-Fluorouracil (5-FU).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Trastuzumab causes reversible LV dysfunction, not acute vasospasm. Reference: 2022 ESC Guidelines on cardio-oncology.\">C) Trastuzumab (Herceptin).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Immune checkpoint inhibitors cause autoimmune myocarditis, not acute vasospasm. Reference: 2022 ESC Guidelines on cardio-oncology.\">D) Nivolumab (Immune Checkpoint Inhibitor).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q12 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q12<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During auscultation of a patient with severe, chronic Aortic Regurgitation (AR), a low-pitched, mid-to-late diastolic rumble is heard at the cardiac apex. What is the eponym for this specific murmur, and what is its mechanism?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Graham Steell is an early diastolic murmur of pulmonary regurgitation in pulmonary hypertension. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">A) Graham Steell murmur; caused by secondary pulmonary regurgitation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The Austin Flint murmur is a functional diastolic rumble heard at the apex in severe AR. It is caused by the severe regurgitant jet from the aorta impinging on the anterior leaflet of the mitral valve, prematurely closing it and creating functional mitral stenosis during diastolic filling. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">B) Austin Flint murmur; caused by the regurgitant jet restricting the opening of the anterior mitral leaflet.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Carey Coombs is a mid-diastolic murmur heard in acute rheumatic fever due to mitral valvulitis. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">C) Carey Coombs murmur; caused by acute rheumatic inflammation of the mitral valve.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Carvallo's sign refers to a tricuspid regurgitation murmur that increases with inspiration. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">D) Carvallo&#8217;s sign; caused by flow across a dilated tricuspid annulus.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q13 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q13<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient presenting with hypertensive emergency is found to have a Pheochromocytoma. When initiating medical therapy to lower the blood pressure prior to surgical resection, what is the mandatory pharmacological sequence?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Beta blockade first leaves alpha receptors unopposed, causing a hypertensive crisis. Reference: 2018 ESC\/ESH Guidelines for the management of arterial hypertension.\">A) Beta-blockade must be initiated first to control heart rate, followed by alpha-blockade.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"ACE inhibitors are not the primary agents for pheochromocytoma management. Reference: 2018 ESC\/ESH Guidelines for the management of arterial hypertension.\">B) ACE inhibitors are the first-line solitary agents for immediate control.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In pheochromocytoma, Alpha-blockade (e.g., phenoxybenzamine or doxazosin) MUST be initiated first. If Beta-blockers are given first, it removes beta-2 mediated vasodilation, leaving the massive catecholamine surge to bind to alpha-1 receptors unopposed, triggering a catastrophic hypertensive crisis. Reference: 2018 ESC\/ESH Guidelines for the management of arterial hypertension.\">C) Alpha-blockade must be initiated first, and Beta-blockers can only be added AFTER adequate alpha-blockade.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Non-dihydropyridine CCBs can be used as adjuncts, but alpha blockade is the mandatory first step. Reference: 2018 ESC\/ESH Guidelines for the management of arterial hypertension.\">D) Intravenous Diltiazem must be initiated first to prevent reflex tachycardia.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q14 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q14<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Adenosine is the first-line drug used to terminate regular narrow-complex tachycardias like AVNRT. What is its specific mechanism of action at the cellular level in the AV node?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes the mechanism of non-dihydropyridine Calcium Channel Blockers (Verapamil\/Diltiazem). Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">A) It directly blocks L-type calcium channels, prolonging phase 0 of the nodal action potential.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Adenosine binds to A1 receptors on the AV node, which activates the acetylcholine-sensitive inward rectifier potassium current (I_K,ACh). This massive potassium efflux hyperpolarizes the cell membrane, suppressing calcium channels and completely (but transiently) blocking AV nodal conduction, breaking the reentrant circuit. Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">B) It activates the inward rectifier potassium current (I_K,ACh), leading to profound cellular hyperpolarization.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes the mechanism of Amiodarone\/Sotalol. Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">C) It blocks the delayed rectifier potassium current (I_Kr), prolonging the effective refractory period.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes Digoxin. Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">D) It inhibits the Na+\/K+ ATPase pump, increasing vagal tone.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q15 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q15<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In a patient diagnosed with an Atrial Septal Defect (ASD), right heart catheterization is performed to calculate the Qp:Qs ratio (Pulmonary to Systemic flow ratio). What Qp:Qs cutoff is generally accepted as the threshold indicating a hemodynamically significant shunt warranting closure?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A ratio of 1.0 indicates no net shunt (normal physiology). Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">A) Qp:Qs &gt; 1.0<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A Qp:Qs ratio &gt;= 1.5 indicates a significant left-to-right shunt (pulmonary blood flow is 1.5 times systemic flow) causing right heart volume overload. This is the classic hemodynamic indication for percutaneous or surgical closure of an ASD. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">B) Qp:Qs &gt;= 1.5<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While a ratio of 2.5 is a massive shunt, the indication for closure begins at 1.5. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">C) Qp:Qs &gt;= 2.5<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A ratio &lt; 1.0 indicates a right-to-left shunt (Eisenmenger physiology), where closure is absolutely contraindicated. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">D) Qp:Qs &lt; 1.0<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q16 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q16<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with a classic Wolff-Parkinson-White (WPW) ECG pattern is being evaluated for catheter ablation. Lead V1 shows a distinctly POSITIVE delta wave and a tall R wave (R\/S ratio &gt; 1). This specific morphology indicates the accessory pathway is located where?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Right free wall pathways produce a left bundle branch block-like pattern (negative delta wave in V1). Reference: Chou's Electrocardiography in Clinical Practice.\">A) Right ventricular free wall.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A positive delta wave and dominant R wave in lead V1 (mimicking Right Bundle Branch Block) indicates that ventricular depolarization is starting on the left side of the heart and moving anteriorly\/rightward toward V1. This localizes the accessory pathway to the LEFT free wall (Type A WPW). Reference: Chou's Electrocardiography in Clinical Practice.\">B) Left ventricular free wall.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Anterior septal pathways typically have a negative or isoelectric delta wave in V1. Reference: Chou's Electrocardiography in Clinical Practice.\">C) Right anteroseptal region.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The Mahaim fiber is a right-sided node-to-fascicle pathway causing an LBBB pattern (negative in V1). Reference: Chou's Electrocardiography in Clinical Practice.\">D) Mahaim fiber (atriofascicular tract).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q17 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q17<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In the cardiac catheterization lab, the Fick Principle is used to calculate Cardiac Output. The formula requires the patient&#8217;s Oxygen Consumption (VO2) and the Arterio-Venous Oxygen difference. Which specific site must the venous blood gas be drawn from to accurately represent true mixed venous oxygen saturation?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The right atrium does not adequately mix blood from the SVC, IVC, and coronary sinus. Reference: Grossman &amp; Baim's Cardiac Catheterization, Angiography, and Intervention.\">A) Right Atrium (RA).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"To accurately calculate Cardiac Output using the Fick method, the venous sample must represent true 'mixed' venous blood (a combination of SVC, IVC, and coronary sinus return). The only place this blood is adequately mixed before entering the lungs is the Pulmonary Artery (PA). Reference: Grossman &amp; Baim's Cardiac Catheterization, Angiography, and Intervention.\">B) Pulmonary Artery (PA).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The SVC only represents upper body venous return. Reference: Grossman &amp; Baim's Cardiac Catheterization, Angiography, and Intervention.\">C) Superior Vena Cava (SVC).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The pulmonary vein carries oxygenated blood returning from the lungs, representing arterial saturation, not venous. Reference: Grossman &amp; Baim's Cardiac Catheterization, Angiography, and Intervention.\">D) Pulmonary Vein.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q18 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q18<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A post-menopausal woman presents with chest pain and ST elevations mimicking an anterior STEMI following sudden emotional distress. Angiography reveals clean coronaries, but the LV gram shows apical ballooning. What is the proposed pathophysiologic mechanism of Takotsubo Cardiomyopathy?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Plaque rupture defines a true Type 1 MI. Reference: 2023 ESC Guidelines for the management of ACS.\">A) Spontaneous rupture of an unstable atherosclerotic plaque with rapid autolysis of the thrombus.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Takotsubo (Stress) Cardiomyopathy is triggered by severe emotional or physical stress. The widely accepted mechanism is a massive catecholamine surge leading to microvascular spasm and direct catecholamine-induced myocardial toxicity\/stunning, which disproportionately affects the apex due to a higher density of beta-adrenergic receptors in that region. Reference: 2023 ESC Guidelines for the management of ACS.\">B) A massive systemic catecholamine surge leading to microvascular spasm and direct myocardial stunning.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Viral entry describes acute viral myocarditis (e.g., Coxsackie B), which has a different clinical trajectory. Reference: 2023 ESC Guidelines for the management of ACS.\">C) Direct viral entry into myocytes via the Coxsackie-Adenovirus receptor.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Spontaneous dissection (SCAD) is a tear in the intima, seen often in young women, but produces a true ischemic territory, not the diffuse apical ballooning of Takotsubo. Reference: 2023 ESC Guidelines for the management of ACS.\">D) Spontaneous coronary artery dissection (SCAD) of the distal LAD.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q19 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q19<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to the Jones Criteria for the diagnosis of Acute Rheumatic Fever, which of the following is considered a MAJOR clinical manifestation?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Fever is a minor criterion. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">A) Documented fever &gt; 38.5\u00b0C.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Arthralgia (joint pain without swelling\/inflammation) is a minor criterion, whereas polyarthritis is a major criterion. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">B) Polyarthralgia (joint pain without objective swelling).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The 5 major Jones Criteria are Carditis, Polyarthritis, Chorea (Sydenham's chorea), Erythema marginatum, and Subcutaneous nodules. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">C) Sydenham&#8217;s Chorea.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Elevated ESR\/CRP is a minor criterion. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">D) Elevated Erythrocyte Sedimentation Rate (ESR) or C-Reactive Protein (CRP).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q20 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q20<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with beta-thalassemia major requires frequent blood transfusions and develops secondary heart failure. Cardiac MRI is ordered to quantify myocardial iron overload. Which specific MRI parameter is the gold standard for measuring tissue iron?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Late Gadolinium Enhancement detects fibrosis\/scar, not iron directly. Reference: 2023 ESC Guidelines for the management of cardiomyopathies.\">A) Late Gadolinium Enhancement (LGE) distribution.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"T1 mapping is used for amyloidosis and extracellular volume (ECV) expansion, not iron. Reference: 2023 ESC Guidelines for the management of cardiomyopathies.\">B) Elevated native T1 mapping times.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"T2* (T2 star) relaxation time is the gold standard for quantifying myocardial iron overload. Iron creates local magnetic field inhomogeneities that rapidly dephase the MRI signal. A T2* &lt; 20 ms indicates myocardial iron overload, and &lt; 10 ms indicates severe overload with high risk of heart failure. Reference: 2023 ESC Guidelines for the management of cardiomyopathies.\">C) Decreased T2* (T2 star) relaxation time.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"T2 mapping (without the star) is primarily used to detect acute myocardial edema (inflammation). Reference: 2023 ESC Guidelines for the management of cardiomyopathies.\">D) Increased T2 mapping times.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q21 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q21<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with a single-chamber ventricular pacemaker (VVI mode) complains of fatigue, dizziness, and a throbbing sensation in their neck (Cannon A waves) during pacemaker firing. What is the diagnosis and mechanism?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Runaway pacemaker causes extreme tachycardia, not necessarily AV dyssynchrony symptoms. Reference: 2021 ESC Guidelines on cardiac pacing.\">A) Runaway Pacemaker Syndrome due to battery depletion.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Twiddler's syndrome involves physical spinning of the device causing lead dislodgement\/phrenic nerve pacing, not cannon A waves. Reference: 2021 ESC Guidelines on cardiac pacing.\">B) Twiddler&#8217;s Syndrome due to lead dislodgement.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Pacemaker Syndrome occurs when there is a loss of AV synchrony (classic in VVI pacing). The ventricle is paced, and the electrical impulse travels retrograde up the AV node, causing the atrium to contract AGAINST a closed tricuspid\/mitral valve. This causes Cannon A waves in the neck, hypotension, and fatigue. Upgrading to a dual-chamber (DDD) pacemaker cures it. Reference: 2021 ESC Guidelines on cardiac pacing.\">C) Pacemaker Syndrome due to loss of atrioventricular (AV) synchrony and retrograde VA conduction.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Pacemaker-Mediated Tachycardia requires an atrial sensing lead (DDD mode) to create an endless loop. Reference: 2021 ESC Guidelines on cardiac pacing.\">D) Pacemaker-Mediated Tachycardia (PMT) due to an endless loop circuit.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q22 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q22<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In patients receiving Cardiac Resynchronization Therapy (CRT) for HFrEF, predicting who will be a &#8220;non-responder&#8221; is clinically important. Which baseline characteristic is the strongest predictor of a POOR response to CRT?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LBBB with a QRS &gt; 150 ms is the strongest predictor of a GOOD response to CRT. Reference: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.\">A) Left Bundle Branch Block (LBBB) morphology with QRS duration &gt; 150 ms.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Patients with Non-LBBB morphologies (particularly Right Bundle Branch Block or nonspecific intraventricular conduction delays) derive significantly less benefit from CRT compared to those with classic LBBB. Non-LBBB morphology is a major predictor of non-response, often yielding a Class IIb or III indication depending on QRS width. Reference: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.\">B) Non-LBBB morphology (e.g., Right Bundle Branch Block).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Non-ischemic cardiomyopathy patients actually tend to respond slightly BETTER to CRT than ischemic patients. Reference: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.\">C) Non-ischemic dilated cardiomyopathy etiology.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Female gender is an independent predictor of a FAVORABLE response to CRT. Reference: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.\">D) Female gender.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q23 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q23<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During an electrophysiology study for Typical AVNRT, mapping of the circuit reveals it uses two pathways. In &#8220;Typical&#8221; (Slow-Fast) AVNRT, what are the antegrade and retrograde pathways, respectively?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Typical AVNRT (accounting for 90% of cases) utilizes the Slow pathway for antegrade conduction (down to the ventricles) and the Fast pathway for retrograde conduction (up to the atria). Because the retrograde conduction is fast, the atria and ventricles depolarize almost simultaneously, burying the P wave inside or just at the end of the QRS (pseudo-R' in V1). Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">A) Antegrade conduction over the Slow pathway; Retrograde over the Fast pathway.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This defines Atypical (Fast-Slow) AVNRT, which produces a long RP tachycardia. Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">B) Antegrade conduction over the Fast pathway; Retrograde over the Slow pathway.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This defines Orthodromic AVRT (utilizing an accessory pathway), not AVNRT. Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">C) Antegrade conduction over the AV node; Retrograde over an accessory pathway.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This defines Antidromic AVRT, not AVNRT. Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">D) Antegrade conduction over an accessory pathway; Retrograde over the AV node.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q24 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q24<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) has an ICD placed due to recurrent VT. What is the classic histopathologic finding in the right ventricle of patients with this disease?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes cardiac sarcoidosis. Reference: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias.\">A) Non-caseating granulomas causing patchy myocardial destruction.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"ARVC is a genetic disorder of the cardiac desmosomes. The classic histopathologic hallmark is the progressive replacement of right ventricular myocardium with fibrofatty (adipose and fibrous) tissue. This creates a highly arrhythmogenic substrate for reentrant ventricular tachycardia. Reference: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias.\">B) Fibrofatty replacement of the right ventricular myocardium.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes amyloidosis. Reference: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias.\">C) Extracellular deposition of misfolded beta-pleated sheet proteins.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes hypertrophic cardiomyopathy (HOCM). Reference: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias.\">D) Massive myocyte hypertrophy with severe myofibrillar disarray.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q25 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-emerald-950 text-teal-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-emerald-500\/30\">Q25<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During an echocardiogram for Mitral Stenosis, the severity is evaluated using Pressure Half-Time (PHT). However, PHT becomes inaccurate (underestimating severity) under which of the following concomitant hemodynamic conditions?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Tricuspid regurgitation does not affect left-sided diastolic equilibration times. Reference: 2017 ASE Guidelines for Noninvasive Evaluation of Native Valvular Regurgitation.\">A) Concomitant severe Tricuspid Regurgitation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Mitral regurgitation actually overestimates mitral stenosis severity when using the mean gradient, but PHT remains relatively valid. Reference: 2017 ASE Guidelines for Noninvasive Evaluation of Native Valvular Regurgitation.\">B) Concomitant moderate Mitral Regurgitation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Pressure Half-Time assumes LV compliance is normal. In severe Aortic Regurgitation (AR), the LV fills rapidly from the aorta during diastole. This rapidly raises LV diastolic pressure, causing the transmitral gradient to drop quickly (a short PHT). This falsely makes the mitral valve appear less stenotic (overestimating the Mitral Valve Area). Planimetry must be used instead. Reference: 2017 ASE Guidelines for Noninvasive Evaluation of Native Valvular Regurgitation.\">C) Concomitant severe Aortic Regurgitation (or decreased LV compliance).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Atrial fibrillation makes averaging beats necessary, but the PHT principle still holds true for individual diastolic filling periods. Reference: 2017 ASE Guidelines for Noninvasive Evaluation of Native Valvular Regurgitation.\">D) Uncontrolled Atrial Fibrillation.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n  <\/div>\n<\/div>\n\n<script>\n  let mcq19Correct = 0;\n  let mcq19Answered = 0;\n  const mcq19Total = 25;\n\n  document.querySelectorAll('#mcq19-quiz-wrapper .quiz-card').forEach(card => {\n    const buttons = card.querySelectorAll('.opt-btn');\n    buttons.forEach(btn => {\n      btn.addEventListener('click', function() {\n        if (card.getAttribute('data-answered') === 'true') return;\n        card.setAttribute('data-answered', 'true');\n        mcq19Answered++;\n\n        document.getElementById('mcq19-answered-count').innerText = mcq19Answered;\n        const pct = (mcq19Answered \/ mcq19Total) * 100;\n        document.getElementById('mcq19-progress-bar').style.width = pct + '%';\n\n        buttons.forEach(b => {\n          b.disabled = true;\n          b.classList.remove('hover:bg-slate-900', 'cursor-pointer');\n          b.classList.add('opacity-50', 'cursor-not-allowed');\n        });\n\n        const isCorrect = this.getAttribute('data-correct') === 'true';\n        const explanation = this.getAttribute('data-explanation');\n\n        if (isCorrect) {\n          mcq19Correct++;\n          document.getElementById('mcq19-correct-count').innerText = mcq19Correct;\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-emerald-950\/80', 'border-emerald-500', 'text-emerald-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10004; CORRECT!<\/span>';\n        } else {\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-red-950\/80', 'border-red-500', 'text-red-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10006; INCORRECT<\/span>';\n\n          buttons.forEach(b => {\n            if (b.getAttribute('data-correct') === 'true') {\n              b.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n              b.classList.add('bg-emerald-950\/40', 'border-emerald-500\/55', 'text-emerald-200', 'opacity-100', 'border-2');\n              b.innerHTML += ' <span class=\"font-bold\">&#10004; (Correct)<\/span>';\n            }\n          });\n        }\n\n        const feedback = card.querySelector('.feedback-box');\n        feedback.innerHTML = `\n          <div class=\"font-extrabold uppercase tracking-widest text-xs mb-2 ${isCorrect ? 'text-emerald-400' : 'text-red-400'}\">\n            ${isCorrect ? 'Clinical Explanation & Reference' : 'Explanation, Correct Answer & Reference'}\n          <\/div>\n          <p class=\"m-0\">${explanation}<\/p>\n        `;\n        feedback.classList.remove('hidden');\n        feedback.classList.add('block', isCorrect ? 'bg-emerald-950\/45' : 'bg-red-950\/20', 'border-2', 'border-solid', isCorrect ? 'border-emerald-500\/30' : 'border-red-500\/30', 'text-slate-200', 'mt-4');\n      });\n    });\n  });\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>\ud83e\uddec Advanced Cardiology Series &#8211; Part 19 Interactive Cardiology MCQs #19 Post-Graduate Level Clinical, Imaging, EP &amp; Structural Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 In patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention (PCI) for an Acute Coronary Syndrome (ACS), the AUGUSTUS trial provided critical guidance on antithrombotic regimens. What was [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":68011,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","nfd_image_url":"","nfd_onboarding_generated":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-68010","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Series of Interactive Cardiology MCQs 19 - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Series of Interactive Cardiology MCQs 19 - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"\ud83e\uddec Advanced Cardiology Series &#8211; Part 19 Interactive Cardiology MCQs #19 Post-Graduate Level Clinical, Imaging, EP &amp; Structural Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 In patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention (PCI) for an Acute Coronary Syndrome (ACS), the AUGUSTUS trial provided critical guidance on antithrombotic regimens. What was [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-31T09:06:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-31T09:42:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1208\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"New Series of Interactive Cardiology MCQs 19\",\"datePublished\":\"2026-10-31T09:06:45+00:00\",\"dateModified\":\"2026-10-31T09:42:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/\"},\"wordCount\":1737,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/\",\"name\":\"New Series of Interactive Cardiology MCQs 19 - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg\",\"datePublished\":\"2026-10-31T09:06:45+00:00\",\"dateModified\":\"2026-10-31T09:42:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg\",\"width\":1208,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Series of Interactive Cardiology MCQs 19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Series of Interactive Cardiology MCQs 19 - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/","og_locale":"en_US","og_type":"article","og_title":"New Series of Interactive Cardiology MCQs 19 - All About Cardiovascular System and Disorders","og_description":"\ud83e\uddec Advanced Cardiology Series &#8211; Part 19 Interactive Cardiology MCQs #19 Post-Graduate Level Clinical, Imaging, EP &amp; Structural Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 In patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention (PCI) for an Acute Coronary Syndrome (ACS), the AUGUSTUS trial provided critical guidance on antithrombotic regimens. What was [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-10-31T09:06:45+00:00","article_modified_time":"2026-10-31T09:42:09+00:00","og_image":[{"width":1208,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"New Series of Interactive Cardiology MCQs 19","datePublished":"2026-10-31T09:06:45+00:00","dateModified":"2026-10-31T09:42:09+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/"},"wordCount":1737,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/","url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/","name":"New Series of Interactive Cardiology MCQs 19 - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg","datePublished":"2026-10-31T09:06:45+00:00","dateModified":"2026-10-31T09:42:09+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-19.jpg","width":1208,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"New Series of Interactive Cardiology MCQs 19"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=68010"}],"version-history":[{"count":3,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68010\/revisions"}],"predecessor-version":[{"id":68014,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68010\/revisions\/68014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/68011"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=68010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=68010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=68010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}